Network Analysis of Inflammatory Bowel Disease Reveals PTPN2 As New Monogenic Cause of Intestinal Inflammation
暂无分享,去创建一个
Jörg Menche | F. Rieux-Laucat | Felix Müller | S. Latour | N. Cerf-Bensussan | M. Thian | K. Boztug | F. Ruemmele | M. Maggioni | M. Parlato | F. Rodrigues‐Lima | B. Bègue | Emmanuel Martin | Julia Pazmandi | R. Duclaux-Loras | F. Charbit-Henrion | Q. Nian | T. Molina | F. Rodrigues-Lima | Thierry Molina | J. Pazmandi | N. Cerf‐Bensussan
[1] J. Cayuela,et al. Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia. , 2019, Blood advances.
[2] C. Picard,et al. Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation , 2019, Gastroenterology.
[3] R. Ardy,et al. Early‐onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms , 2018, Immunological reviews.
[4] Balaraman Ravindran,et al. Network-based features enable prediction of essential genes across diverse organisms , 2018, PloS one.
[5] M. Tremblay,et al. Protein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease , 2018, Front. Immunol..
[6] P. Visscher,et al. Common Disease Is More Complex Than Implied by the Core Gene Omnigenic Model , 2018, Cell.
[7] L. Rönnblom,et al. T cells are influenced by a long non-coding RNA in the autoimmune associated PTPN2 locus. , 2018, Journal of autoimmunity.
[8] H. Uhlig,et al. A Spectrum of Genetic Variants Contributes to Immune Defects and Pathogenesis of Inflammatory Bowel Diseases. , 2018, Gastroenterology.
[9] F. Rieux-Laucat,et al. Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study , 2018, Journal of Crohn's & colitis.
[10] G. Rogler,et al. PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer. , 2018, Cell reports.
[11] K. Hao,et al. A functional genomics predictive network model identifies regulators of inflammatory bowel disease , 2017, Nature Genetics.
[12] Yang I Li,et al. An Expanded View of Complex Traits: From Polygenic to Omnigenic , 2017, Cell.
[13] Daniel G. MacArthur,et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity , 2017, Nature.
[14] A. Fischer,et al. Primary immunodeficiencies suggest redundancy within the human immune system , 2016, Science Immunology.
[15] Alexis Battle,et al. Co-expression networks reveal the tissue-specific regulation of transcription and splicing , 2019 .
[16] O. Delaneau,et al. Estimating the causal tissues for complex traits and diseases , 2016, Nature Genetics.
[17] David C. Wilson,et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.
[18] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[19] G. Rogler,et al. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing , 2016, Digestion.
[20] Lluis Quintana-Murci,et al. The mutation significance cutoff: gene-level thresholds for variant predictions , 2016, Nature Methods.
[21] Damian Smedley,et al. Next-generation diagnostics and disease-gene discovery with the Exomiser , 2015, Nature Protocols.
[22] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[23] Christopher Y. Park,et al. Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases. , 2015, Immunity.
[24] Judy H. Cho,et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.
[25] J. Cools,et al. A RP-UFLC Assay for Protein Tyrosine Phosphatases: Focus on Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2) , 2015, Scientific Reports.
[26] Laurent Beaugerie,et al. Cancers complicating inflammatory bowel disease. , 2015, The New England journal of medicine.
[27] Albert-László Barabási,et al. A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome , 2015, PLoS Comput. Biol..
[28] B. Becher,et al. PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis , 2014, Mucosal Immunology.
[29] M. Daly,et al. Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.
[30] Damian Smedley,et al. Walking the interactome for candidate prioritization in exome sequencing studies of Mendelian diseases , 2014, Bioinform..
[31] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[32] G. Guariso,et al. Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age , 2013, Gastroenterology research and practice.
[33] Peggy Hall,et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..
[34] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[35] M. Tremblay,et al. Strain-Dependent Differences in Bone Development, Myeloid Hyperplasia, Morbidity and Mortality in Ptpn2-Deficient Mice , 2012, PloS one.
[36] M. Tremblay,et al. T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. , 2011, The Journal of clinical investigation.
[37] Fiona Powrie,et al. Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.
[38] Rodrigo Lopez,et al. A new bioinformatics analysis tools framework at EMBL–EBI , 2010, Nucleic Acids Res..
[39] A. Ferrando,et al. Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia , 2009, Nature Genetics.
[40] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[41] R. A. Bailey,et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.
[42] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[43] M. Tremblay,et al. TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-{gamma}. , 2007, Blood.
[44] N. Tonks,et al. Protein tyrosine phosphatases: from genes, to function, to disease , 2006, Nature Reviews Molecular Cell Biology.
[45] Ambuj K. Singh,et al. Analysis of protein-protein interaction networks using random walks , 2005, BIOKDD.
[46] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[47] E. Newell,et al. T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. , 2004, Blood.
[48] Manuel C. Peitsch,et al. SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..
[49] Sven Branner,et al. Structure Determination of T Cell Protein-tyrosine Phosphatase* , 2002, The Journal of Biological Chemistry.
[50] M. Tremblay,et al. The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3 , 2002, Current Biology.
[51] John Wagner,et al. Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.
[52] Jörg Menche,et al. Supplementary Materials for Uncovering disease-disease relationships through the incomplete interactome , 2014 .
[53] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[54] N. Gulbahce,et al. Network medicine: a network-based approach to human disease , 2010, Nature Reviews Genetics.